TrialCritical care (London, England)2012

A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock.

Peter E Morris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.